FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309040016> ?p ?o ?g. }

• W4309040016 endingPage "152112" @default.
• W4309040016 startingPage "152112" @default.
• W4309040016 abstract "Clinical trial design requires value judgements and understanding patient preferences may help inform these judgements, for example when prioritizing treatment candidates, designing complex interventions, selecting appropriate outcomes, determining clinically important thresholds, or weighting composite outcomes. Preference elicitation methods are quantitative approaches that can estimate patients' preferences to quantify the absolute or relative importance of outcomes or other attributes relevant to the decision context. We aimed to explore stakeholder perceptions of using preference elicitation methods to inform judgements when designing clinical trials in rheumatology.We conducted 1-on-1 semi-structured interviews with patients with rheumatic diseases and rheumatology clinicians/researchers, recruited using purposive and snowball sampling. Participants were provided pre-interview materials, including a video and a document, to introduce the topic of preference elicitation methods and case examples of potential applications to clinical trials. Interviews were conducted via Zoom and were audio-recorded and transcribed. We used thematic analysis to analyze our data.We interviewed 17 patients and 9 clinicians/researchers, until data and inductive thematic saturation were achieved within each group. Themes were grouped into overall perceptions, barriers, and facilitators. Patients and clinicians/researchers generally agreed that preference elicitation studies can improve clinical trial design, but that many considerations are required around preference heterogeneity and feasibility. A key barrier identified was the additional resources and expertise required to measure and incorporate preferences effectively in trial design. Key facilitators included developing guidance on how to use preference elicitation to inform trial design, as well as the role of external decision-makers in developing such guidance, and the need to leverage the movement towards patient engagement in research to encourage including patient preferences when designing trials.Our findings allowed us to consider the potential applications of patient preferences in trial design according to stakeholders within rheumatology who are involved in the trial process. Future research should be conducted to develop comprehensive guidance on how to meaningfully include patient preferences when designing clinical trials in rheumatology. Doing so may have important downstream effects for shared decision-making, especially given the chronic nature of rheumatic diseases." @default.
• W4309040016 created "2022-11-21" @default.
• W4309040016 creator A5005178337 @default.
• W4309040016 creator A5010734100 @default.
• W4309040016 creator A5022067453 @default.
• W4309040016 creator A5026433456 @default.
• W4309040016 creator A5031263099 @default.
• W4309040016 creator A5034266471 @default.
• W4309040016 creator A5036388757 @default.
• W4309040016 creator A5036470851 @default.
• W4309040016 creator A5039764074 @default.
• W4309040016 creator A5044637906 @default.
• W4309040016 creator A5049401142 @default.
• W4309040016 creator A5052496992 @default.
• W4309040016 creator A5058802040 @default.
• W4309040016 creator A5060799862 @default.
• W4309040016 creator A5067518918 @default.
• W4309040016 creator A5070327307 @default.
• W4309040016 creator A5082086756 @default.
• W4309040016 creator A5087940101 @default.
• W4309040016 date "2023-02-01" @default.
• W4309040016 modified "2023-09-25" @default.
• W4309040016 title "Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration" @default.
• W4309040016 cites W1532938164 @default.
• W4309040016 cites W1979290264 @default.
• W4309040016 cites W2002030263 @default.
• W4309040016 cites W2048709304 @default.
• W4309040016 cites W2121821727 @default.
• W4309040016 cites W2135168058 @default.
• W4309040016 cites W2170816415 @default.
• W4309040016 cites W2735594032 @default.
• W4309040016 cites W2754799758 @default.
• W4309040016 cites W2908430308 @default.
• W4309040016 cites W2937063244 @default.
• W4309040016 cites W2940519132 @default.
• W4309040016 cites W2994541683 @default.
• W4309040016 cites W3014397681 @default.
• W4309040016 cites W3045617647 @default.
• W4309040016 cites W3095503834 @default.
• W4309040016 cites W3123093787 @default.
• W4309040016 cites W3155774611 @default.
• W4309040016 cites W3165806139 @default.
• W4309040016 cites W3198242311 @default.
• W4309040016 cites W4200551038 @default.
• W4309040016 doi "https://doi.org/10.1016/j.semarthrit.2022.152112" @default.
• W4309040016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36372015" @default.
• W4309040016 hasPublicationYear "2023" @default.
• W4309040016 type Work @default.
• W4309040016 citedByCount "0" @default.
• W4309040016 crossrefType "journal-article" @default.
• W4309040016 hasAuthorship W4309040016A5005178337 @default.
• W4309040016 hasAuthorship W4309040016A5010734100 @default.
• W4309040016 hasAuthorship W4309040016A5022067453 @default.
• W4309040016 hasAuthorship W4309040016A5026433456 @default.
• W4309040016 hasAuthorship W4309040016A5031263099 @default.
• W4309040016 hasAuthorship W4309040016A5034266471 @default.
• W4309040016 hasAuthorship W4309040016A5036388757 @default.
• W4309040016 hasAuthorship W4309040016A5036470851 @default.
• W4309040016 hasAuthorship W4309040016A5039764074 @default.
• W4309040016 hasAuthorship W4309040016A5044637906 @default.
• W4309040016 hasAuthorship W4309040016A5049401142 @default.
• W4309040016 hasAuthorship W4309040016A5052496992 @default.
• W4309040016 hasAuthorship W4309040016A5058802040 @default.
• W4309040016 hasAuthorship W4309040016A5060799862 @default.
• W4309040016 hasAuthorship W4309040016A5067518918 @default.
• W4309040016 hasAuthorship W4309040016A5070327307 @default.
• W4309040016 hasAuthorship W4309040016A5082086756 @default.
• W4309040016 hasAuthorship W4309040016A5087940101 @default.
• W4309040016 hasBestOaLocation W43090400161 @default.
• W4309040016 hasConcept C119857082 @default.
• W4309040016 hasConcept C144024400 @default.
• W4309040016 hasConcept C151730666 @default.
• W4309040016 hasConcept C15744967 @default.
• W4309040016 hasConcept C162324750 @default.
• W4309040016 hasConcept C175444787 @default.
• W4309040016 hasConcept C190248442 @default.
• W4309040016 hasConcept C2777868144 @default.
• W4309040016 hasConcept C2779318504 @default.
• W4309040016 hasConcept C2779343474 @default.
• W4309040016 hasConcept C2781249084 @default.
• W4309040016 hasConcept C36289849 @default.
• W4309040016 hasConcept C41008148 @default.
• W4309040016 hasConcept C509550671 @default.
• W4309040016 hasConcept C71924100 @default.
• W4309040016 hasConcept C74196892 @default.
• W4309040016 hasConcept C75630572 @default.
• W4309040016 hasConcept C86803240 @default.
• W4309040016 hasConcept C87156501 @default.
• W4309040016 hasConceptScore W4309040016C119857082 @default.
• W4309040016 hasConceptScore W4309040016C144024400 @default.
• W4309040016 hasConceptScore W4309040016C151730666 @default.
• W4309040016 hasConceptScore W4309040016C15744967 @default.
• W4309040016 hasConceptScore W4309040016C162324750 @default.
• W4309040016 hasConceptScore W4309040016C175444787 @default.
• W4309040016 hasConceptScore W4309040016C190248442 @default.
• W4309040016 hasConceptScore W4309040016C2777868144 @default.
• W4309040016 hasConceptScore W4309040016C2779318504 @default.
• W4309040016 hasConceptScore W4309040016C2779343474 @default.

• next